Intravitreal Aflibercept Injection for Radiation Retinopathy
Status:
Completed
Trial end date:
2019-03-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of intravitreal aflibercept injection - in
the treatment of macular edema associated with retinopathy secondary to previous radiation
therapy.